Genprex
在场
Genprex 是一家在股票代码 GNPX (US) 下上市的公司。
高管
查看带有其 19 名主要高管的组织结构图
Genprex 搜索最多的简介
- Ryan Confer, Director, President and Chief Executive Officer
- Jose Moreno, Director
- Brent Longnecker, Director
高管在Genprex变化
- Jose Moreno Toscano 曾任 Board Member, 现升职为 Non-Executive Chairman of the Board (新闻发布的2024五月14号).
- Rodney Varner, Chairman of the Board and Chief Executive Officer, 已经去世。我们深感遗憾 (新闻发布的2024五月9号).
- Ryan Confer 曾任 Chief Financial Officer, 现升职为 Director, President and Chief Executive Officer (新闻发布的2024五月9号).
创建提醒
跟踪 Genprex 的高管变动
生物技术
Genprex 拥有 2,289 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Attovia Therapeutics 刚刚宣布为 150 筹款数百万美元。 (公布2024五月14号).
- Bruker has announced the acquisition of NanoString Technologies (公布2024五月13号).
- Aardvark Therapeutics 刚刚宣布为 85 筹款数百万美元。 (公布2024五月12号).
生物技术 行业的其他推荐联系人
消息
Genprex 的最新新闻稿
- Genprex to Present and Participate at Upcoming May Investor and Industry Conferences - Genprex
- May 2024 - Genprex
- Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System - Genprex
- April 2024 - Genprex
- Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer - Genprex
- Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting - Genprex
- Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Genprex
- Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Genprex
- Press Releases Archives - Page 20 of 20 - Genprex
- Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa® Immunogene Therapy with PD-1 and PD-L1 Antibodies to Treat Cancers - Genprex
- View more press releases Close
通过电子邮件
